Integrating Bilinear Transduction with Message Passing Neural Networks for Improved ADMET Property Prediction

25 June 2025, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

With the increasing application of machine learning and deep learning in drug discovery comes the significant challenge of addressing censored molecular property datasets. Pharmaceutical assays frequently generate censored data where measurement limitations prevent recording exact values beyond predetermined thresholds. Standard deep learning approaches struggle with this censoring, often producing systematic prediction errors even for in-distribution molecules. Building on the established strengths of Chemprop and the concept of bilinear transduction, we present a method that integrates bilinear transduction into the Chemprop message-passing neural network. This integration allows us to effectively leverage domain-specific structural relationships between molecules, addressing current limitations in molecular property prediction. Our comprehensive evaluation across multiple ADMET (absorption, distribution, metabolism, excretion, and toxicity) properties demonstrate that our method outperforms standard D-MPNN baselines, with improvements exceeding 100% for heavily censored datasets like CYP2C9 inhibition and CYP2D6 inhibition. This practical solution requires no additional experimental measurements while improving ADMET property prediction accuracy, particularly in the challenging high-censoring regimes common in pharmaceutical research.

Keywords

ADMET
deep learning
data censoring
graph neural networks

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.